Auna (NYSE:AUNA) Issues Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Auna (NYSE:AUNA) released its earnings results on Tuesday. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.11), FiscalAI reports. Auna had a return on equity of 13.32% and a net margin of 0.44%.The company had revenue of $362.85 million during the quarter, compared to analyst estimates of $357.39 million.

Auna Stock Performance

NYSE:AUNA opened at $5.42 on Thursday. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm has a 50-day moving average of $5.17 and a two-hundred day moving average of $5.11. The stock has a market cap of $401.13 million, a P/E ratio of 77.44 and a beta of 0.61. Auna has a 1-year low of $4.09 and a 1-year high of $6.85.

Analyst Ratings Changes

AUNA has been the topic of a number of research analyst reports. JPMorgan Chase & Co. reduced their target price on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Wall Street Zen lowered Auna from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 5th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research report on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $6.97.

Insider Transactions at Auna

In other Auna news, President Leon Jesus Zamora bought 6,420 shares of the company’s stock in a transaction dated Friday, May 29th. The shares were acquired at an average cost of $4.15 per share, with a total value of $26,643.00. Following the completion of the transaction, the president owned 69,130 shares in the company, valued at $286,889.50. The trade was a 10.24% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John Wilton sold 17,574 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $4.17, for a total value of $73,283.58. Following the completion of the transaction, the director owned 49,974 shares in the company, valued at approximately $208,391.58. This trade represents a 26.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have bought 77,640 shares of company stock worth $331,539.

Institutional Trading of Auna

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Marshall Wace LLP increased its position in shares of Auna by 391.0% in the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after purchasing an additional 129,799 shares during the last quarter. Jane Street Group LLC bought a new position in shares of Auna during the fourth quarter worth about $201,000. Squarepoint Ops LLC bought a new position in shares of Auna during the fourth quarter worth about $196,000. XTX Topco Ltd acquired a new position in Auna in the fourth quarter worth about $162,000. Finally, Goldman Sachs Group Inc. acquired a new position in Auna in the first quarter worth about $219,000.

Auna Company Profile

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.